Wie hoch ist der Preis für BIOLASE, Inc. (BIOL)

Preis für BIOLASE, Inc. (BIOL) ist $0.00695

Wie hoch ist die Marktkapitalisierung für BIOLASE, Inc. (BIOL)

Marktkapitalisierung für BIOLASE, Inc. (BIOL) ist $536.40

BIOLASE, Inc. (BIOL) EPS

BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.

Jahr	EPS	ändert
2026 (TTM)	$-2.24	-86.12%
2023	$-16.14	-96.09%
2022	$-413.19	51.12%
2021	$-273.41	-60.27%
2020	$-688.19	-64.23%
2019	$-1.92K	-26.36%
2018	$-2.61K	-8.52%
2017	$-2.86K	-9.83%
2016	$-3.17K	-27.29%
2015	$-4.36K	-17.16%
2014	$-5.26K	27.87%
2013	$-4.11K	268.72%
2012	$-1.12K	-35.23%
2011	$-1.72K	-67.15%
2010	$-5.24K	299.39%
2009	$-1.31K	-67.76%
2008	$-4.07K	23.72%
2007	$-3.29K	52.80%
2006	$-2.15K	-73.70%
2005	$-8.19K	-24.15%
2004	$-10.80K	-210.06%
2003	$9.81K	589.36%
2002	$1.42K	-731.00%
2001	$-225.54	-89.24%
2000	$-2.10K	0.00%

Jahr

EPS

ändert

2026 (TTM)

$-2.24

-86.12%

2023

$-16.14

-96.09%

2022

$-413.19

51.12%

2021

$-273.41

-60.27%

2020

$-688.19

-64.23%

2019

$-1.92K

-26.36%

2018

$-2.61K

-8.52%

2017

$-2.86K

-9.83%

2016

$-3.17K

-27.29%

2015

$-4.36K

-17.16%

2014

$-5.26K

27.87%

2013

$-4.11K

268.72%

2012

$-1.12K

-35.23%

2011

$-1.72K

-67.15%

2010

$-5.24K

299.39%

2009

$-1.31K

-67.76%

2008

$-4.07K

23.72%

2007

$-3.29K

52.80%

2006

$-2.15K

-73.70%

2005

$-8.19K

-24.15%

2004

$-10.80K

-210.06%

2003

$9.81K

589.36%

2002

$1.42K

-731.00%

2001

$-225.54

-89.24%

2000

$-2.10K

0.00%

Unternehmen	EPS	EPS-Differenz	Land
Abbott Laboratories ABT.US	$3.11	-238.84%	US
Stryker Corporation SYK.US	$9.73	-534.38%	US
Medtronic plc MDT.US	$3.59	-260.27%	IE
Boston Scientific Corporation BSX.US	$2.48	-210.71%	US
Edwards Lifesciences Corporation EW.US	$1.74	-177.68%	US

Unternehmen

EPS

EPS-Differenz

Land